Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
Menha SwellamLobna Ezz El ArabAmr S Al-PosttanySamy B SaidPublished in: Journal of neuro-oncology (2019)
Detection of circulating miR-221 and miR-222 may be used as circulating molecular marker for diagnosis and prediction of outcome for patients with GBM. Further studies with large cohort of samples are encouraged.